# 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

> **NCT04403971** · NA · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 103 (actual)

## Conditions studied

- Hospital-acquired Pneumonia

## Interventions

- **DRUG:** 0.12% Chlorhexidine Oral Liquid Product
- **DRUG:** Listerine Oral Liquid Product
- **OTHER:** Normal Saline Product

## Key facts

- **NCT ID:** NCT04403971
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-25
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403971, "0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04403971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*